CFAR Scientific Symposium

2015 CFAR Scientific Symposium : HIV Persistence

Progress and Problems in the Search for an HIV Cure


Integrating HIV Latency

  • Anthony S. Fauci, MD
    An HIV Cure: Obstacles and Opportunities
  • Robert F. Siliciano, MD, PhD
    Measuring and Clearing the Latent Reservoir for HIV

Immunological/Molecular Basis of Persistence

  • Nicolas Chomont, PhD
    The Role Of T Cell Homeostasis In HIV Persistence
  • James I. Mullins, PhD
    Host Cell Provirus Integration Sites And Maintenance Of HIV Reservoirs

Early ART

  • Katherine F. Ruiz de Luzuriaga, MD
    Limiting HIV Persistence And Achieving HIV Cure In Children: Advances And Challenges
  • Jintanat Ananworanich, MD, PhD
    Early ART: A Critical Step In Clinical Trials Towards HIV Remission

Shock and Kill

  • Romas Geleziunas, PhD
    Therapeutic Strategies Aiming To Achieve ART-Free HIV Remission
  • Martin Tolstrup, PhD
    Clinical Experience With HIV Latency Reversing Agents

Vaccines and Antibodies

  • Jeffrey D. Lifson, MD
    NHP Models And Therapeutic Vaccination In HIV Cure Research
  • Dan H. Barouch, MD, PhD
    Monoclonal Antibodies For HIV-1 Therapy And Eradication

Gene and Cell Therapy

  • Timothy J. Henrich, MD
    Stem Cell Transplantation, Cytoreductive Chemotherapy And HIV-1 Persistence
  • W. David Hardy, MD
    A Gene-modified Stem Cell and CD4+ T Cells Approach to Curing HIV/AIDS -the Calimmune Perspective
Planning Committee
Mike McCune, MD, PhD
Head, HIV Frontiers Global Health Innovative Technology Solutions Bill & Melinda Gates Foundation
César Cadabes
Community Engagement and Communications Program Analyst